Motilal Oswal Nifty Alpha 50 ETF · NSE:MOALPHA50
Motilal Oswal Nifty Alpha 50 ETF — Motilal Oswal Asset Management Company — Investor Presentation (August 2021)
26 slides from Motilal Oswal Nifty Alpha 50 ETF's investor presentation, August 2021
Slide 1: IOP V2
MOTILAL OswaL BUY RIGHT ASSET MANAGEMENT| IOP V2 August 2021 THINK EQUITY. THINK MOTILAL OSWAL.
Slide 2: Smallcaps offer a larger opportunity for Alpha generation
Smallcaps offer a larger opportunity for Alpha generation • Top 20 stocks Dispersion of 3Yr CAGR account for 31% of Index weight but 100.00% contributes 230% of the total price 80.00% returns 26% of Index • Nifty Smallcap 60.00% weight, Mean 100 Returns for 3 returns: 36% years: -8.4% 40.00% • Dispe
Slide 3: SmallCaps offer a larger Opportunity for Alpha generation
SmallCaps offer a larger Opportunity for Alpha generation • Small Caps are covered by fewer analysts, this gives fund manager an edge in spotting good businesses early • Ownership pattern is not broad based as information is limited –this category is best played through a focused portfolio Under Res
Slide 4: Why now? - Expect smallcaps to bounce back with economic recovery
Why now? - Expect smallcaps to bounce back with economic recovery Small-cap 100/ Nifty 50 Nifty 50 Nifty Midcap 100 Nifty Smallcap 100 1.00 185 0.89 151 0.90 135 0.73 132 0.80 115 0.70 0.66 85 0.60 0.50 0.56 35 0.40 Mar-18 May-18 Oct-18 Nov-18 Mar-19 May-19 Oct-19 Nov-19 Mar-20 May-20 Oct-20 Nov-20
Slide 5: Small caps growth is strongly correlated with GDP growth
Small caps growth is strongly correlated with GDP growth Pre-Covid economic recovery saw IOP V2 beginning to outperform. However, Covid has significantly set back both the economy and IOP Post-Covid green shoots of economic recovery visible and FY22 should see full impact Small-Cap Performance
Slide 6: Small caps can grow 100x in 10 years
Small caps can grow 100x in 10 years Many businesses in India offer huge growth potential Bajaj Finance – Market Cap Trend (INR cr) 200,000 174,827 Small caps, given their size, have a long runway for 133,337 150,000 growth 100,000 The full benefit of this is reaped by those investors who 50,0
Slide 7: Historically Low PEG : Earnings Growth and Valuations in a Sweet Spot
Historically Low PEG : Earnings Growth and Valuations in a Sweet Spot QGLP Philosophy Favourable Market Cap Mix Quality RoE: 21% FY24E Sector Mix Others, Discretionary Large Cap, Consumption & 13% 4% Allied, 11% Non Lending Growth 36% PAT CAGR over FY21 – 24E Financials, Auto Ancillaries, Mid Cap, 1
Slide 8: Low PEG : WCS23 'Valuation Insights' - Evidence Suggests It's the Best Time to Buy
Low PEG : WCS23 ‘Valuation Insights’ - Evidence Suggests It’s the Best Time to Buy PEG is short for P/E to Growth ratio : TTM P/E divided by 3 yrs forward earnings growth PEG- What Works & What Doesn't In the 23rd Annual Wealth Creation Study, we used the PEG Average 3Yr Instances from Ratio with 3-
Slide 9: Low PEG : WCS23 'Valuation Insights' - Evidence Suggests It's the Best Time to Buy
Low PEG : WCS23 ‘Valuation Insights’ - Evidence Suggests It’s the Best Time to Buy Period 2013-18 1 yr 2 yr 3 yr 4 yr 5 yr Sensex Return 19% 22% 10% 12% 12% PEG < 1x Return 36% 61% 38% 45% 39% Alpha 17% 39% 28% 33% 27% • Efficacy of PEG ratio is remarkable irrespective of the number of years of grow
Slide 10: Portfolio Positioning and High Conviction Bets
Portfolio Positioning and High Conviction Bets THINK EQUITY THINK MOTILAL OSWAL
Slide 11: 58% of the portfolio is allocated towards beneficiaries of economic recovery
58% of the portfolio is allocated towards beneficiaries of economic recovery Aegis Logistics 7% Economy Recovery Plays NBFCs Quess Corp 4% NBFCs, 5% Can Fin Homes 5% Economy Blue Dart 1% Recovery Play, 16% ITD Cementation 1% Discretionary Consumption HEG 1% & Allied 12% Consumption & Allied Engineer
Slide 12: 41% of the portfolio remains invested in Compounders
41% of the portfolio remains invested in Compounders Alkem Labs 4% Healthcare Mahanagar Gas 7% Ipca Labs 3% Dhanuka Agritech 3% Others Healthcare Gland Pharma 4% Bayer Cropscience 1% 12% Clean Science & 2% Technology Others, 12% Insurance Max Financial Services 5% Insurance Limited 5% Non Lending IC
Slide 13: Portfolio Performance
Portfolio Performance Alpha of 2.4% CAGR since inception THINK EQUITY THINK MOTILAL OSWAL
Slide 14: Portfolio Performance
Portfolio Performance IOP V2 Strategy Nifty Smallcap 100 TRI 15 13 1.4X 11 1.3X 9 7 5 3 One lac invested in the Dec-19 Dec-18 Dec-20 Sep-18 Nov-18 Sep-19 Nov-19 Sep-20 Nov-20 Jun-18 Jun-19 Jun-20 Jun-21 May-19 May-21 Mar-18 Apr-18 May-18 Aug-18 Oct-18 Jan-19 Mar-19 Apr-19 Jan-20 Mar-20 Apr-20 May-20
Slide 15: Portfolio Allocation
Portfolio Allocation Top 10 Holdings & Market Capitalization Sectoral Allocation Scrip Name % Holding Non-Lending Financials 16.3 Consumer Discretionary 13.6 Birla Corporation Limited 7.0 Oil & Gas 13.2 ICICI Securities Limited 6.8 Pharmaceuticals 11.1 Construction 7.9 Mahanagar Gas Limited 6.7 Auto
Slide 16: Key Portfolio Stocks
Key Portfolio Stocks THINK EQUITY THINK MOTILAL OSWAL
Slide 17: Central Depository Services (India) Limited
PORTFOLIO 4.6% WEIGHT: I CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED Strong Macro variables to Improving macro variables (demographics, per capita income), push support the Growth towards financial inclusion, and shift in savings towards financial assets bodes well for capital market intermediaries
Slide 18: ICICI Securities Ltd.
PORTFOLIO 6.8% WEIGHT: II ICICI SECURITIES Ltd. Industry tailwinds Strong post-Covid ADTO trend has extended in the 2QFY21 too. Over 3m demat accounts were opened in the past four months. Impact of regulations No impact on ISEC due to the new margin norms or share pledging norms that came into effec
Slide 19: Max Financials
PORTFOLIO 5.0% WEIGHT: III MAX FINANCIALS Strong underlying insurance business With best in class metrics (20%+ VNB Margins, 20% RoEVs) and growth track record (20%+ EV compounding). Axis Bank overhang on verge of resolution Axis Bank emerging as the single largest shareholder with 18% stake, subjec
Slide 20: Gland Pharma
PORTFOLIO 3.9% WEIGHT: IV GLAND PHARMA 100% focus on injectable across different formats, High backward Unique Business Model integration, No Front end and own pipeline of molecules : A win win for both partners and suppliers. High Longevity Injectables forms 40% share of the global Pharma market of
Slide 21: The portfolio manager invests with an eye on the future
The portfolio manager invests with an eye on the future Investors who invest in the good times and hold back in the bad times can never make above average returns. THINK EQUITY THINK MOTILAL OSWAL
Slide 22: Small Cap stocks are a volatile and unpredictable lot… but provide an opportunity for upside
Small Cap stocks are a volatile and unpredictable lot… but provide an opportunity for upside To earn super-normal returns with small cap stocks: • Be patient • Never exit looking at rear-view performance • Double up at extremes if possible THINK EQUITY 22 THINK MOTILAL OSWAL
Slide 23: Chairman – Investment Committee
Chairman – Investment Committee Raamdeo Agrawal Chairman, MOFSL Raamdeo Agrawal is the Co-Founder of Motilal Oswal Financial Services Limited (MOFSL). As Chairman of Motilal Oswal Asset Management Company, he has been instrumental in evolving the investment management philosophy and framework.
Slide 24: Portfolio Manager
Portfolio Manager Manish Sonthalia • Manish has been managing the Strategy since inception and also serves as the Director of the Motilal Oswal India Fund, Mauritius. • He has over 25 years of experience in equity research and fund management, with over 14 years with Motilal Oswal PMS. • He has been
Slide 25: Disclaimer
Disclaimer Disclaimer: This presentation has been prepared and issued on the basis of internal data, publicly available information and other sources believed to be reliable. The information contained in this document is for general purposes only and not a complete disclosure of every material fact
Slide 26: Thank You!
Thank You! THINK EQUITY THINK MOTILAL OSWAL
Motilal Oswal Asset Management Company — Investor Presentation (August 2021) on 6ix